Cookies on our website

We use cookies on our website. To learn more about cookies, how we use them on our site and how to change your cookie settings please view our cookie policy. By continuing to use this site without changing your settings you consent to our use of cookies in accordance with our cookie policy.

Read more Close
Skip Ribbon Commands
Skip to main content
Sign In

Publications

Biosimilar Substitution in France: No Way Back?

 

08 January 2014

Beginning on 1 January 2014, French pharmacists are now legally permitted to substitute a biosimilar for the prescribed (reference) biological medicine as long as the prescribing physician has not marked the prescription as “non-substitutable”.  According to the new law, substitution is allowed only when initiating a course of treatment, and if the biosimilar belongs to the same grouping as the prescribed product, known as a “similar biologic group.”  These groupings will be drawn up by the French health care authority ANSM. 

 

Read more >>

Publications search




Key people

Laetitia Benard
Laetitia Benard
Partner
France
Telephone icon+33 (0)1 40 06 50 33
Send email
View officeView profile
Alexandre Rudoni
Alexandre Rudoni
Partner
France
Telephone icon+33 (0)1 40 06 50 34
Send email
View officeView profile
Eveline Van Keymeulen
Eveline Van Keymeulen
Counsel
France
Telephone icon+33 (0)1 40 06 54 00
Send email
View officeView profile

Client alerts

Already signed up for Client alerts? Click here to access your portal



  • Add comment (optional)